Recent research found that anti-CD73 antibodies alone showed no effect but when combined with radiotherapy or chemotherapy, an immune-checkpoint blockade leads to a synergetic anti-tumor response and anti-metastatic activity [238]. This evidence concerns the gene NT5E and neoplasm.